Общая реаниматология

Расширенный поиск

Ишемическое и фармакологическое прекондиционирование (часть 2)

Полный текст:


Список литературы

1. Рябов Г. А.

2. Mangano D. T.Perioperative cardiac morbidity. Anesthesiology 1990; 72 (1): 153—184.

3. Mangano D. T., Browner W. S., Hollenberg M. et al.Association of peri-operative myocardial ischemia with cardiac morbility and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N. Engl. J. Med. 1990; 323 (26): 1781—1788.

4. Warltier D. C., Pagel P. S., Kersten J. R.Approaches to the prevention of peri-operative myocardial ischemia. Anesthesiology 2000; 92 (1): 253—259.

5. De Hert S. G., van der Linden P. J., ten Broecke P. W. et al.Effects of desflu-ran and sevoflurane on length-dependent regulation of myocardial function in coronary surgery patients. Anesthesiology 2001; 95 (2): 357—363.

6. Schlack W., Hollmann M., Stunneck J., Thamer V.Effect of halothane on myocardial reoxygenation injury in the isolated rat heart. Br. J. Anaesth. 1996; 76 (6): 860—867.

7. Cason B. A., Gamperl A. K., Slocum R. E., Hickey R. F.Anesthetic-induced precondicioning: previous administration of isoflurane decreases myocardial infarct size in rabbits. Anesthesiology 1997; 87 (5): 1182—1190.

8. Minguer G., Joris J., Lamy M.Precondicioning and protection against ischaemia-reperfusion in non-cardiac organs: a place for volatile anaesthetics? Eur. J. Anaesth. 2007; 24 (9): 733—745.

9. Zheng S., Zuo Z.Isoflurane precondicioning induces neuroprotection against ischemia via activation of p38 mitogen-activated protein kinase. Mol. Pharmacol. 2004; 65 (5): 1172—1180.

10. Payne R. S., Akca O., Roewer N. et al.Sevofluran-induced precondi-cioning protects against cerebral ischemic neuronal damage in rats. Brain Res. 2005; 1034 (1—2): 147—152.

11. Luo Y., Ma D., Ieong E. et al.Xenon and sevofluran protect against brain injury in a neonatal asphyxia model. Anesthesiology 2008; 109 (5): 782—789.

12. De Hert S. G., Turani F., Mathur S., Stowe D. F.Cardioprotection with volatile anesthetics: mechanisms and clinical implications. Anesth. Analg. 2005; 100 (6): 1584—1593.

13. Belhomme D., Peynet J., Louzy M. et al.Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 1999; 100 (19 Suppl): II340—II344.

14. Tomai F., De Paulis R., Penta de Peppo A. et al.Beneficial impact of isoflurane during coronary bypass surgery on troponin I release. G. Ital. Cardiol. 1999; 29 (9): 1007—10

15. Julier K., da Silva R., Garcia C. et al.Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery (A double-blinded, placebo-controlled, multicenter study). Anesthesiology 2003; 98 (6): 1315—1327.

16. De Hert S. G., ten Broecke P. W., Mertens E. et al.Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 2002; 97 (1): 42—49.

17. De Hert S. G., Cromheecke S., ten Broecke P. W. et al.Effects of propo-fol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients. Anesthesiology 2003; 99 (2): 314—323.

18. Conzen P. F., Fisher S., Detter C., Peter K.Sevoflurane provides greater protection of the myocardium than propofol in pations undergoing off-pump coronary artery bypass surgery. Anesthesiology 2003; 99 (4): 826—833.

19. Bein B., Renner J., Caliebe D. et al.Sevoflurane but not propofole preserves myocardial function during minimally invasive direct coronary artery bypass surgery. Anesth. Analg. 2005; 100 (3): 610—616.

20. Garcia C.,Julier K., Bestmann L. et al.Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery. Br. J. Anaesth. 2005; 94 (2): 159—165.

21. Yu C. H., Beattie W. S.The effects of volatile anesthetics on cardiac ischemic complications and mortality in CABG: a meta-analysis. Can. J. Anesth. 2006; 53 (9): 906—918.

22. Symons J. A., Myles P. S.Myocardial protection with volatile anaesthetics agents during coronary artery bypass surgery: a meta-analisis. Br. J. Anaesth. 2006; 97 (2): 127—136.

23. Crisostomo P. R., Wairiuko G. M., Wang M. et al.Preconditioning versus postconditioning: mechanisms and therapeutic potentials. J. Am. Coll. Surg. 2006; 202 (5): 797—812.

24. De Her S. G., Longrois D., Yang H., Fleisher L. A.Does the use of a volatile anesthetic regimen attenuate the incidence of cardiac events after vascular surgery? Acta Anaesthesiol. Belg. 2008; 59 (1): 19—25.

25. Weber N. C., Precker B., Shlack W.The effect of anesthetics on the myocardium — new insights into protection . Eur. J. Anaesth. 2005; 22 (9): 647—657.

26. KehlF., KrolikowskiJ. G., Mraoic B. et al.Hyperglycemia prevents isoflu-rane -induced preconditioning against myocardial infarction. Anesthesiology 2002; 96 (1): 183—188.

27. Шевченко Ю. Л., Гороховатский Ю. И., Азизова О. А., Замятин М. Н.Системный воспалительный ответ при экстремальной хирургической агрессии. М.: РАЕН; 2009.

28. Toller W. G., Gross E. R., Kersten J. R. et al.Sarcolemmal and and mito-chondrial adenosine triphosphate-dependent potassium channels: Mechanism of desflurane-induced cardioprotection. Anesthesiology 2000; 92 (6): 1731—1739.

29. Tanaka K., Ludwig L. M., Krolikowski J. G. et al.Isoflurane produces delayed precondicioning against myocardial ischemia a reperfusion injury: role of cyclooxygenase-2. Anesthesiology 2004; 100 (3): 525—531.

30. Fradorf J., Huhn R..,Weber N. C. et al.Sevofluran-induced precondi-cioning: impact of protocol and aprotinin administration on infarct size and endothelial nitric-oxide synthase phosphorilation in rat the heartin vivo.Anesthesiology 2010; 113 (6): 1289—1298.

31. Juhaszova M., Rabuel C., Zorov D. B. et al.Protection in the aged heart: preventing the heart-break of old age? Cardiovasc. Res. 2005; 66 (2): 233—244.

32. Dutch National Medical Registry (

33. Lakatta E. G., Sollott S. J.The heartbreak of older age. Mol. Interv. 2002; 2 (7): 431—446.

34. Tani M., Suganuma Y., Hasegawa H. et al.Decrease in ischemic tolerance with aging isolated perfused Fischer 344 rat hearts: relation to increases in intracellular Na+ after ischemia. J. Mol. Cell. Cardiol. 1997; 29 (11): 3081—3089.

35. Ferdinandy P., Schulz R., Baxter G. T.Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol. Rev. 2007; 59 (4): 418—458.

36. Kilts J. D., Akazawa T., Richardson M. D., Kwatra M. M.Age increases cardiac G alpha expression, resulting in enhanced coupling to G protein-coupled receptors. J. Biol. Chem. 2002; 277 (34): 31257—31262.

37. Lee T. M., Su S. F., Chou T. F. et al.Loss of precondicioning by attenuated activation of myocardial ATP-sensitive potassium channels in elderly patients undergoing coronary angioplasty. Circulation 2002; 105 (3): 334—340.

38. Jimenez-Navarro M., Gomez-Doblas J. J., Alonso J. et al.Does angina the week before protect against first myocardial infarction in elderly patients? Am. J. Cardiol. 2001; 87 (1): 11—15.

39. Rosenfeldt F. L., Pepe S., Linnane A. et al.The effects of ageing on the response to cardiac surgery: protective strategies for the ageing myocardium. Biogerontology 2002; 3 (1—2): 37—40.

40. Juhaszova M., Zorov D. B., Kim S. H. et al.Glycogen syntase kinase-3 mediates convergence of protection signaling to inhibit the mitochon-drial permeability transition pore. J. Clin. Invest. 2004; 113 (11): 1535—1549.

41. Гребенчиков О. А., Мурачев А. С., Левиков Д. И. и соавт.Ингаляционная индукция на основе севофлурана у пожилых больных высокого риска в некардиальной хирургии. Общая реаниматология 2011; VII (3): 59—62.

42. Przyklenk K., Darling C. E., Dickson E. W., Whittaker P.Cardioprotection «outside the box» — the evolving paradigm of remote preconditioning. Basic Res. Cardiol. 2003; 98 (3): 149—157.

43. Przyklenk K., Bauer B., Ovize M. et al.Regional ischemic «preconditioning» protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 1993; 87 (3): 893—899.

44. Dickson E. W., Lorbar M., Porcaro W. A. et al.Rabbit heart can be «pre-conditioned» via transfer of coronary effluent. Am. J. Physiol. 1999; 277 (6 Pt 2): H2451—H2457.

45. Hausenloy D. J., Yellon D. M.Remote ischeamic preconditioning: underlying mechanisms and clinical application. Cardiovasc. Res. 2008; 79 (3): 377—386.

46. Hausenloy D. J., Mwamure P. K., Venugopal V. et al.Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 2007; 370 (9587): 575—579.

47. Ali Z. A., Callaghan C.J., Lim E. et al.Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation 2007; 116 (11 Suppl): I98—I205.

48. ЛомиворотовВ. В., ПономарёвД. Н., ШмырёвВ. А. исоавт.Общая реаниматология 2011; VII (3): 63—69.

49. Brevoord D., Hollmann M. W., De Hert S. G. et al.Effect of remote ischemic conditioning on atrial fibrillation and outcome after coronary artery bypass grafting (RICO-trial). BMC Anesthesiology 2011; 11: 11.

50. Rosenkranz E. R., Buckberg G. D.Myocardial protection during surgical coronary reperfusion. J. Am. Coll. Cardiol. 1983; 1 (5): 1235—1246.

51. Preckel B., Schlack W.Effects of anesthetics on ischemia-reperfusion injury of the heart. In: Vincent J. L. (ed.). Yearbook of Intensive Care and Emergency Medicine. Berlin: Springer; 2002. 165—176.

52. De Heart S. G., van der Linden P. G., Cromheecke S. et al.Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 2004; 101 (2): 299—310.

53. Ebel D., Schlack W., Comfere T. et al.Effect of propofol on reperfusion injury after regional ischemia in the isolated rat heart. Br. J. Anaesth. 1999; 83 (6): 903—908.


Для цитирования:

Лихванцев В.В., Мороз В.В., Гребенчиков О.А., Гороховатский Ю.И., Заржецкий Ю.В., Тимошин С.С., Левиков Д.И., Шайбакова В.Л. Ишемическое и фармакологическое прекондиционирование (часть 2) . Общая реаниматология. 2012;8(1):61.

For citation:

Likhvantsev V.V., Moroz V.V., Grebenchikov O.A., Gorokhovatsky Yu.I., Zarzhetsky Yu.V., Timoshin S.S., Levikov D.I., Shaibakova V.L. Ischemic and Pharmacological Preconditioning (part 2) . General Reanimatology. 2012;8(1):61. (In Russ.)

Просмотров: 1165

Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.

ISSN 1813-9779 (Print)
ISSN 2411-7110 (Online)